Sly usedC6m cells in studies of 2292-16-2 Cancer opioid signalling like AC sensitization (Clark et al., 2004; Clark and Traynor, 2006) and have shown similar m-opioid-mediated sensitization in HEK cells (Clark and Traynor, 2006). We’ve got compared the ability to precipitate expression of AC sensitization and the pharmacological profiles of naltrexone and 6b-naltrexol, in addition to the standard opioid antagonist naloxone, the peptidic antagonist CTAP and also the recognized d-opioid inverse agonist (+)N-[trans-4-(2-methylphenyl)-2-butenyl]-(3R,4R)-dimethyl-4(3-hydroxyphenyl)piperidine (RTI-5989-25; Zaki et al., 2001). The results show that there’s no inherent efficacy distinction in between 6b-naltrexol and naltrexone below the circumstances studied and in addition that development and manifestation of AC sensitization will not be dependent on the formation of a constitutively active m-opioid receptor.MethodsCell culture and treatment options C6 rat glioma cells stably transfected with the rat m-opioid receptor (C6m) or HEK293 cells stably transfected using the FLAG-tagged mouse m-opioid receptor had been grown to confluence in Dulbecco’s modified Eagle’s medium (DMEM) containing 0.five mg L-1 or 0.eight mg L-1 Geneticin respectively. Cells were grown in the presence of 10 fetal bovine serum at 37 in 5 CO2. For chronic opioid treatment, cells have been incubated overnight with 10 mmol -1 DAMGO ([D-Ala2,NMe-Phe4,Glyol5]-enkephalin). C6m cells were employed for all experiments except for the determination of cell surface receptor number, which utilized HEK cells expressing a FLAGtagged m-opioid receptor. C6m cells expressed three.2 0.2 pmol g-1 protein receptor and HEK cells 9.7 1.3 pmol g-1 protein receptor, determined by [3H]diprenorphine binding.Membrane preparation Cells were washed twice with ice cold phosphate-buffered saline (0.9 NaCl, 0.61 mmol -1 Na2HPO4 and 0.38 mmol -1 KH2PO4, pH 7.4), detached from the plate by incubation in harvesting buffer (20 mmol -1 HEPES, pH 7.four, 150 mmol -1 NaCl and 0.68 mmol -1 EDTA) and pelleted by centrifugation. The resulting pellet was suspended in cold 50 mmol -1 Tris buffer, pH 7.four and LY3023414 Cancer homogenized with a Tissue Tearor (Biospec Products Inc., Bartlesville, OK). The homogenate was centrifuged at 18 000g at 4 for 20 min, and also the pellet resuspended in 50 mmol -1 Tris, homogenized with a Tissue Tearor and recentrifuged. The final pellet was resuspended in 50 mmol -1 Tris, aliquoted and stored at -80 until use. Protein concentration was measured by the strategy of Bradford (1976).[3H]Diprenorphine binding For competitive binding, cell membranes were incubated for 75 min at 25 with varying concentrations (0.1 nmol -11 mmol -1) of ligand and 0.2 nmol -1 [3H]diprenorphine in 50 mmol -1 Tris, pH 7.four with and without the need of the presence of 100 mmol -1 NaCl and ten mmol -1 GTPgS. Non-specificBritish Journal of Pharmacology (2009) 156 1044m-Opioid antagonists and inverse agonists MF Divin et albinding was determined inside the presence of 10 mmol -1 naloxone. Assays have been stopped by fast filtration by way of glass microfiber filtermats, type GF/C (Whatman, Clifton, NJ) by using a Brandell harvester (Gaithersburg, MD) followed by washing with cold 50 mmol -1 Tris buffer. Filtermats were dried, and 0.1 mL Ecolume was added to each sample. Filtermats were heat sealed in polyethylene bags, and radioactivity retained on the filters was measured by liquid scintillation counting in a Wallac 1450 MicroBeta Liquid Scintillation and Luminescence Counter (Perkin Elmer, Boston, MA). [35S]GTPgS [Gu.
